(Bloomberg) -- Iceland is joining its Nordic peers in halting inoculations with Moderna Inc.’s Spikevax shot on concern over side effects.
The Moderna jab, which has mostly been used in Iceland for second doses, won’t be used until more information over its safety has been collected, the chief epidemiologist said on Friday.
Sweden, Denmark and Finland have this week suspended the jabs for younger people because of the risk of heart inflammation as a potential side effect. Norway said men under 30 should consider choosing the Pfizer Inc.’s and BioNTech SE’s rival vaccine, and the other Nordic nations also recommended that as an alternative. Both vaccinations use messenger RNA technology to prompt an immune reaction.
©2021 Bloomberg L.P.
BNN Bloomberg Picks
Opportunities in luxury retail: Three hot picks from John San Marco
Majority of Canadians determined to own a home despite affordability challenges: Survey
Started a side hustle? Seek expert advice to avoid tax season headaches
It's possible to have 'too much' in your RRSP: Tax expert
Food prices set to increase — again — as blackout on price hikes ends at some stores
WestJet temporarily suspends service from 3 Canadian cities to Europe